Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Dec 1996, 3056-3062, Vol 34, No. 12
Z Wang, BG Hansson, O Forslund, L Dillner, M Sapp, JT Schiller, B Bjerre and J Dillner
To investigate whether cervical mucus antibodies against human
papillomavirus (HPV) capsids are associated with the detection of HPV DNA
or HPV-related cytological diagnoses, 611 samples of cervical secretions
from 359 women referred to a colposcopy clinic were tested by an
enzyme-linked immunosorbent assay for the presence of immunoglobulin A
(IgA) antibodies against HPV capsids of HPV type 16, 18, or 33 and for the
presence of cervical HPV DNA by PCR. Among subjects with at least one
cervical sample positive for HPV type 16 (HPV-16) DNA, 28.1% also had at
least one HPV-16 IgA-positive cervical sample (odds ratio [OR] = 2.9; P =
0.0003). IgA to HPV-18 was also more common among HPV-18 DNA-positive
subjects (OR = 3.1; P = 0.0325) and IgA to HPV-33 was more common among
HPV-33 DNA-positive subjects (OR = 4.2; P = 0.0023). Cervical IgA
antibodies to HPV-16 were also more common among patients with cervical
intraepithelial neoplasia, particularly among patients with cervical
intraepithelial neoplasia grade I (P < 0.0005). The data indicate that
an HPV type-restricted IgA antibody response against HPV capsids is
detectable in cervical mucus and is associated with a concomitant cervical
HPV infection.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|